The initial dose used was 80 units daily and this was reduced by decrements of 20 units in accordance with clinical improvement. As the dose was reduced the peak cortisol decreased, the mean 5-hour value after 80 units being significantly greater than that after 40 units and 20 units. The duration of response also correlated with the size of the dose, the 24-hour value after 80 units being above the normal range and significantly greater than that after all the smaller doses. Of these 10 patients treated with corticotrophin, 6 went into remission. Four required surgery within four weeks of starting on corticotrophin, but the adrenal response of the 4 patients who came to surgery did not differ significantly from that of those who went into remission. Thus there seemed to be no correlation between the clinical response and the responsiveness of the adrenals to corticotrophin.
Estimation of plasma cortisol may be helpful in the management of colitis. In the patient not responding to prednisone a normal cortisol level will show the drug is not having the expected effect on adrenal function and the patient may benefit from a change of therapy. In the patient not improving on corticotrophin a relatively poor adrenal response as judged by cortisol levels may be an indication for supplementary steroid treatment or for increasing the dose of corticotrophin.
Immunosuppressive Therapy in Ulcerative Colitis Twelve cases of ulcerative colitis have been treated with azathioprine (Imuran). Two cases have been excluded from this report, as steroids may have played a large part in their recovery. Ten cases are therefore presented ( Table 1) .
The series covers all grades of non-specific ulcerative colitis, from acute ulcerative to mild chronic granular proctocolitis. It includes 2 patients with severe proctitis who had previously been treated by colectomy. The histories varied from two months to seven years. Eight cases had previously received systemic and/or local steroid therapy with varying results.
On immunosuppressive therapy, 9 cases have shown complete symptomatic recovery, and in 6 cases remission has been maintained with no treatment except sulphasalazine (Salazopyrin). This drug was added in relapsing cases while azathioprine was withdrawn. Four cases are currently being weaned off treatment after six weeks to four months, one case having shown little improvement.
Dosage with azathioprine has been high (not less than 5 mg/kg daily), as experience of treating other conditions with this drug has suggested that it is necessary to produce some leucopenia if significant therapeutic results are to be obtained. The dose was invariably 300 mg, daily in the first week and on 6 days per week in the second and subsequent weeks. If the white cell count fell to 2,000/c.mm, or the platelet count to below 100,000/c.mm, azathioprine was omitted on two consecutive days per week.
Latterly, to avoid marrow depression, the drug was omitted for 2 days a week initially, and prednisone, 20 mg a day, has been added to cover the days on which azathioprine was omitted. No significant fall in the white cell or platelet count was apparent in these cases and the therapeutic effect of the combined treatment seemed to be as good as when azathioprine was given alone continuously until the white count fell. From this limited experience, this regime appears to have much to commend it.
In 5 cases azathioprine was given alone, with dramatic symptomatic response in all, and with sigmoidoscopic cure in 2. In 2 cases complete resolution of the mucosal changes could not be achieved when the dose of azathioprine was reduced. Two or three days' steroid cover for the days when off azathioprine produced complete remission symptomatically and sigmoidoscopically. In one very severe case who had tetracycline in addition to azathioprine alone, treatment was Section ofProctology 501 deemed to be too hazardous after ten days, in spite of marked symptomatic improvement. Azathioprine was therefore stopped and orthodox high dosage steroid therapy substituted. After three weeks, progress was so unsatisfactory that azathioprine was added and the steroids rapidly reduced. There was rapid improvement and complete healing occurred on azathioprine alone. Three of the series were failed steroid cases, and on moderate local or systemic steroid dosage remission could not be achieved. Azathioprine in full dosage was then added and, after improvement occurred, the steroid dose was rapidly reduced in all except one, who had had continuous steroid therapy for five years without remission. In all 3 cases, complete remission symptomatically and sigmoidoscopically was achieved and maintained on azathioprine alone.
Two post-operative cases have been treated. In one, with a severe proctitis complicating ileorectal anastomosis, complete control was obtained but he remains on treatment, and the two days when off azathioprine are covered by prednisone. In the other, a severe chronic proctitis of seven years' duration in a large isolated rectal stump, the response has been disappointing, with little apart from symptomatic improvement. In this case, however, severe fibrosis and shrinkage of the organ has occurred and it measures only lOxS 15 cm.
Dr E Mary Cooke (St Bartholomew's Hospital, London)
Escherichia coli and Ulcerative Colitis Because the lesions of ulcerative colitis are in close contact with very large numbers of microorganisms, the possible role of these in initiating or exacerbating the disease has aroused considerable interest. However, investigations of this disease have generally failed to demonstrate that bacteria are of importance in the pathogenesis of ulcerative colitis (Weinstein 1961).
I have compared quantitatively the fmcal flora of 20 patients suffering from an attack of ulcera-tive colitis with that of 20 normal persons. The organisms looked for were principally coliforms, lactobacilli, streptococci and bacteroides. The viable counts of these organisms were similar in both groups of people, but the viable counts of enterococci were slightly higher in the faces of ulcerative colitis patients and they were isolated from a higher number of these patients than from normal people (Cooke 1967) .
I also examined one group of organisms, the Escherichia coli, in detail. The coliforms were isolated from the fices of 50 patients during an attack of ulcerative colitis, from 50 normal people and from 50 people with acute diarrhcea. The properties studied were: (1) Hemolysin production.
(2) Necrotoxin production: this was tested by intradermal injection in rabbits. (3) Serotype: antisera to 'O' groups 1, 2, 4, 5, 6, 7, 8, 9, 11, 18, 39 and 75 were prepared and the E. coli were typed using these antisera. (4) Effect on ligated rabbit ileal segments.
It is known that enteropathogenic E. coli produce a positive reaction in this test (Taylor et al. 1958) . In this work, two types of positive reaction were obtained, a hemorrhagic response and a polymorphonuclear one.
Results
The results obtained are shown in Table 1 .
More of the strains from ulcerative colitis patients produced hamolysin, necrotoxin and were 'O' typable with the small numbers of antisera used than were strains from other sources. Five of the 20 ulcerative colitis strains gave a positive reaction in ligated rabbit ileal segments and one of 15 normal strains gave a positive reaction in this test (Cooke 1968). It has been suggested by previous workers that the strains of Escherichia coli in pathological material differ from those found in the faces of normal people. This has been suggested in the case of peritonitis, appendicitis and urinary tract infections. In the case of urinary tract infection the pathogenicity of the infecting strain of Escherichia coli is clear. It is very much less so in ulcerative colitis. There appears, however, to be a possibility that these strains of Escherichia coli 
